MediSync Clinical Research

Petal, Mississippi 39465

0 studies enrolling now · 4 studies all time

What they study most

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Melanoma, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol, Type 2 Diabetes

Studies at this site

• A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
• A Study of LY3437943 in Participants With Type 2 Diabetes — Completed
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma — Stopped early